[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fqTFKd7d6dVv-7P2ksXJ1RopWkO_ijec8y8zBOvX-fzY":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":32,"type":33},[],"2025-11-15 17:16:59",234592376,[8,9,10,11,12],"停药反应","毒性反应","变态反应","副反应","后遗效应",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},119,"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","exam_167706155","模块一 药理学总论","患者,女,55岁,既往有高血压病史,长期服用可乐定治疗,后因无药而终止服药,因头疼、震颤、出汗及心悸1天入院,查体37.5℃,血压78\u002F125mmHg,心率115次\u002F分钟.以上现象属于( )",[22,34,44,51,59,69,79,82,87,97],{"answer":23,"createTime":5,"id":24,"options":25,"question":31,"source":32,"type":33},[],234592370,[26,27,28,29,30],"A=C>B","A>B=C","A=B>C","A>B>C","A>C>B","A 、B 、C 三药的 LD50 分别为 40 、40 、60mg\u002Fkg ,ED50 分别为 10 、20 、20mg \u002Fkg, 比较三药的安全性大小的顺序为( )","v1",0,{"answer":35,"createTime":5,"id":36,"options":37,"question":43,"source":32,"type":33},[],234592371,[38,39,40,41,42],"碱性尿液>胃液>血液","血液>胃液>碱性尿液","胃液>血液>碱性尿液","血液>碱性尿液>胃液","碱性尿液>血液>胃液","某弱酸性药物 pKa =3.4,若已知胃液、血液和碱性尿液的 pH 值分别是 1.4、 7.4 和 8.4 .问该药物在理论上达到平衡时,哪里的浓度高?( )",{"answer":45,"createTime":5,"id":46,"options":47,"question":50,"source":32,"type":33},[],234592372,[9,12,11,48,49],".特异质反应","继发反应","患者服治疗量的伯氨喹所致的溶血反应( )",{"answer":52,"createTime":5,"id":53,"options":54,"question":58,"source":32,"type":33},[],234592373,[8,55,56,12,57],"耐受性","生理依赖性","耐药性","连续用药后机体对药物的反应性降低是( )",{"answer":60,"createTime":5,"id":61,"options":62,"question":68,"source":32,"type":33},[],234592374,[63,64,65,66,67],"以数量的分级来表示群体反应的效应强度","以数量的分级来表示群体中某一效应出现的频率","在某一群体中某一效应出现的个数","在某一群体中某一效应出现的频率","以数量的分级来表示个体反应的效应强度","量反应是指 ( )",{"answer":70,"createTime":5,"id":71,"options":72,"question":78,"source":32,"type":33},[],234592375,[73,74,75,76,77],"无效","不变","减弱","相反","增强","对乙酰氨基酚主要被肝药酶转化,与异烟肼(酶抑制剂)合用时的效应比单独应用的效应是( )",{"answer":80,"createTime":5,"id":6,"options":81,"question":20,"source":32,"type":33},[],[8,9,10,11,12],{"answer":83,"createTime":5,"id":84,"options":85,"question":86,"source":32,"type":33},[],234592377,[49,11,9,48,12],"阿托品在治疗解除胃痉挛时所致的心悸( )",{"answer":88,"createTime":5,"id":89,"options":90,"question":96,"source":32,"type":33},[],234592378,[91,92,93,94,95],"达峰时间","表观分布容积","曲线下面积","清除率","半衰期","可反映药物吸收快慢的指标是( )",{"answer":98,"createTime":5,"id":99,"options":100,"question":101,"source":32,"type":33},[],234592379,[9,12,48,11,49],"巴比妥类药物所致的次晨宿醉现象( )"]